1. The combination of decoy receptor 3 and soluble triggering receptor expressed on myeloid cells-1 for the diagnosis of nosocomial bacterial meningitis.
- Author
-
Yong-Juan Liu, Li-Hua Shao, Jian Zhang, Shan-Ji Fu, Gang Wang, Feng-Zhe Chen, Feng Zheng, Rui-Ping Ma, Hai-Hong Liu, Xiao-Meng Dong, and Li-Xian Ma
- Subjects
RECEPTOR antibodies ,MYELOID leukemia ,LEUKEMIA treatment ,NOSOCOMIAL infections ,BACTERIAL meningitis ,DEATH forecasting ,BACTERIAL disease treatment ,THERAPEUTICS - Abstract
Background: Early diagnosis and appropriate antibiotic treatment can significantly reduce mortality of nosocomial bacterial meningitis. However, it is a challenge for clinicians to make an accurate and rapid diagnosis of bacterial meningitis. This study aimed at determining whether combined biomarkers can provide a useful tool for the diagnosis of bacterial meningitis. Methods: A retrospective study was carried out. Cerebrospinal fluid (CSF) levels of decoy receptor 3 (DcR3) and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) were detected by enzyme-linked immunosorbent assay (ELISA). Results: The patients with bacterial meningitis had significantly elevated levels of the above mentioned biomarkers. The two biomarkers were all risk factors with bacterial meningitis. The biomarkers were constructed into a "bioscore". The discriminative performance of the bioscore was better than that of each biomarker, with an area under the receiver operating characteristic (ROC) curve (AUC) of 0.842 (95% confidence intervals (CI) 0.770-0.914; p< 0.001). Conclusions: Combined measurement of CSF DcR3 and sTREM-1 concentrations improved the prediction of nosocomial bacterial meningitis. The combined strategy is of interest and the validation of that improvement needs further studies. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF